AHA 2019: French Registry Data Favor Edwards’ Sapien TAVR Over Medtronic’s CoreValve
The study’s authors say head-to-head randomized trials of the latest transcatheter aortic valves are urgently needed
Executive Summary
Registry data from France shows transcatheter aortic valve replacement patients have better outcomes with Edwards’ Sapien balloon-expandable valves than with Medtronic’s CoreValve self-expanding valves.